Found: 36
Select item for more details and to access through your institution.
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 7, p. 1748, doi. 10.1007/s12094-024-03399-3
- By:
- Publication type:
- Article
Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS).
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 10, p. 2950, doi. 10.1007/s12094-023-03159-9
- By:
- Publication type:
- Article
Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 6, p. 1756, doi. 10.1007/s12094-023-03073-0
- By:
- Publication type:
- Article
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 3, p. 445, doi. 10.1007/s10549-023-06926-y
- By:
- Publication type:
- Article
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 111, doi. 10.1007/s10549-021-06274-9
- By:
- Publication type:
- Article
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 657, doi. 10.1007/s10549-020-05970-2
- By:
- Publication type:
- Article
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 469, doi. 10.1007/s10549-017-4658-x
- By:
- Publication type:
- Article
Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab.
- Published in:
- Neuro-Oncology Practice, 2017, v. 4, n. 1, p. 15, doi. 10.1093/nop/npw004
- By:
- Publication type:
- Article
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1184021
- By:
- Publication type:
- Article
Avoiding Axillary Treatment in Sentinel Lymph Node Micrometastases of Breast Cancer: A Prospective Analysis of Axillary or Distant Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 3, p. 772, doi. 10.1245/s10434-009-0804-y
- By:
- Publication type:
- Article
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2393, doi. 10.3390/cancers14102393
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 151, n. 3, p. 597, doi. 10.1007/s10549-015-3415-2
- By:
- Publication type:
- Article
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 3, p. 1161, doi. 10.1007/s10549-012-2149-7
- By:
- Publication type:
- Article
Pseudoprogression as an adverse event of glioblastoma therapy.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2858, doi. 10.1002/cam4.1242
- By:
- Publication type:
- Article
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63637-w
- By:
- Publication type:
- Article
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47642-2
- By:
- Publication type:
- Article
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.645026
- By:
- Publication type:
- Article
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1851, doi. 10.1093/neuonc/noaa107
- By:
- Publication type:
- Article
Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 11, p. 1470, doi. 10.1093/neuonc/noz130
- By:
- Publication type:
- Article
Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
- By:
- Publication type:
- Article
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.
- Published in:
- BMC Pharmacology & Toxicology, 2019, v. 20, n. 1, p. N.PAG, doi. 10.1186/s40360-019-0367-x
- By:
- Publication type:
- Article
Bevacizumab for the Treatment of Glioblastoma.
- Published in:
- Clinical Medicine Insights: Oncology, 2013, n. 7, p. 123, doi. 10.4137/CMO.S8503
- By:
- Publication type:
- Article
Bevacizumab for the Treatment of Glioblastoma.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 123, doi. 10.4137/CMO.S8503
- By:
- Publication type:
- Article
Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161484
- By:
- Publication type:
- Article
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 613, doi. 10.1007/s11523-020-00754-6
- By:
- Publication type:
- Article
Bevacizumab in Recurrent Glioblastoma: Efficacy Benchmarks and Safety in Different Doses, Combinations, Time and Situations.
- Published in:
- Cancer & Chemotherapy Reviews, 2014, v. 9, n. 2, p. 51
- By:
- Publication type:
- Article
Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 515, doi. 10.1007/s11060-019-03183-2
- By:
- Publication type:
- Article
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 363, doi. 10.1007/s11060-017-2660-0
- By:
- Publication type:
- Article
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 569, doi. 10.1007/s11060-016-2065-5
- By:
- Publication type:
- Article
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00625-7
- By:
- Publication type:
- Article
A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1854, doi. 10.1634/theoncologist.2020-0417
- By:
- Publication type:
- Article
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 521, doi. 10.1634/theoncologist.2018-0290
- By:
- Publication type:
- Article
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.
- Published in:
- Journal of the Peripheral Nervous System, 2016, v. 21, n. 3, p. 134, doi. 10.1111/jns.12177
- By:
- Publication type:
- Article
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00707
- By:
- Publication type:
- Article